EPCAM and neoplasm: High expression of EpCAM can be positive for treatment outcome based on its role in cell–cell adhesion [69,109], in proliferation [38,39], in endomesodermal differentiation [70], and, as first described here, as a regulatory molecular determinant of tumor cell differentiation along the EMT axis through modulation of EGFR-dependent pERK1/2.